Lawrence, KS, United States of America

Anand C Burman

This inventor holds 1 USPTO granted patent. Top assignee: Interx Research Corporation. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anand C Burman. Retrieved from https://idiyas.com/inventor/anand-c-burman-bftbu5bw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anand C Burman

Introduction

Anand C Burman is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triamterene derivatives. His research focuses on enhancing the solubility and bioavailability of pharmaceutical compounds.

Latest Patents

Anand C Burman holds 1 patent for his invention titled "Aldehyde adducts of triamterene." This invention provides novel aldehyde adducts of triamterene that exhibit improved solubility and bioavailability compared to the original compound. The patent also describes pharmaceutical compositions containing these novel adducts, which demonstrate diuretic activity.

Career Highlights

Anand C Burman is associated with Interx Research Corporation, where he continues to advance his research in pharmaceutical innovations. His work has the potential to significantly impact the development of new therapeutic agents.

Collaborations

Anand collaborates with Takeru Higuchi, a fellow researcher, to further explore the applications of his inventions in the pharmaceutical industry.

Conclusion

Anand C Burman's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of research in improving drug efficacy. His work exemplifies the ongoing efforts to enhance medical treatments for better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…